Your browser doesn't support javascript.
loading
The effects of docosahexaenoic acid supplementation on cognition and well-being in mild cognitive impairment: A 12-month randomised controlled trial.
Mengelberg, Alexia; Leathem, Janet; Podd, John; Hill, Stephen; Conlon, Cathryn.
Affiliation
  • Mengelberg A; School of Psychology, Massey University Wellington, Wellington, New Zealand.
  • Leathem J; School of Psychology, Massey University Wellington, Wellington, New Zealand.
  • Podd J; School of Psychology, Massey University Manawatu, Palmerston North, New Zealand.
  • Hill S; School of Psychology, Massey University Manawatu, Palmerston North, New Zealand.
  • Conlon C; School of Sport, Exercise and Nutrition, Massey University Albany, Auckland, New Zealand.
Int J Geriatr Psychiatry ; 37(5)2022 05.
Article in En | MEDLINE | ID: mdl-35373862
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Docosahexaenoic Acids / Cognitive Dysfunction Type of study: Clinical_trials Aspects: Patient_preference Limits: Aged / Humans Language: En Journal: Int J Geriatr Psychiatry Journal subject: GERIATRIA / PSIQUIATRIA Year: 2022 Document type: Article Affiliation country: New Zealand Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Docosahexaenoic Acids / Cognitive Dysfunction Type of study: Clinical_trials Aspects: Patient_preference Limits: Aged / Humans Language: En Journal: Int J Geriatr Psychiatry Journal subject: GERIATRIA / PSIQUIATRIA Year: 2022 Document type: Article Affiliation country: New Zealand Country of publication: United kingdom